{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:39:39Z","timestamp":1776087579464,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1111,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.ijrobp.2009.06.042","type":"journal-article","created":{"date-parts":[[2009,10,31]],"date-time":"2009-10-31T04:52:33Z","timestamp":1256964753000},"page":"1105-1112","source":"Crossref","is-referenced-by-count":47,"title":["Locoregional Outcomes of Inflammatory Breast Cancer Patients Treated With Standard Fractionation Radiation and Daily Skin Bolus in the Taxane Era"],"prefix":"10.1016","volume":"77","author":[{"given":"Shari","family":"Damast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica N.","family":"Fornier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Ishill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Elkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Beal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beryl","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2009.06.042_bib1","first-page":"580","article-title":"Inflammatory carcinoma of the breast: A report of twenty-eight cases from the breast clinic of the Memorial Hospital","volume":"39","author":"Lee","year":"1924","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib2","series-title":"Diseases of the breast","author":"Haagensen","year":"1971"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/cncr.22927","article-title":"Inflammatory breast cancer (IBC) and patterns of recurrence: Understanding the biology of a unique disease","volume":"110","author":"Cristofanilli","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib4","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.2003.07.082","article-title":"Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: Distinct clinicopathologic entities?","volume":"21","author":"Anderson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib5","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1200\/JCO.2004.04.068","article-title":"Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy","volume":"22","author":"Low","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/1097-0142(197903)43:3<985::AID-CNCR2820430330>3.0.CO;2-1","article-title":"Results of treating stage III carcinoma of the breast by primary radiation therapy","volume":"43","author":"Bruckman","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002800050664","article-title":"Combined-modality treatment of inflammatory breast carcinoma: Twenty years of experience at M.D. Anderson Cancer Center","volume":"40","author":"Ueno","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01806692","article-title":"Combined modality treatment of locally advanced breast cancer: Adjuvant combination chemotherapy with and without doxorubicin","volume":"9","author":"Casper","year":"1987","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF02307059","article-title":"Therapy for inflammatory breast cancer: Impact of doxorubicin-based therapy","volume":"2","author":"Bauer","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib10","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","article-title":"The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27","volume":"21","author":"Bear","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"Citron","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib12","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/1097-0142(20011001)92:7<1775::AID-CNCR1693>3.0.CO;2-E","article-title":"Paclitaxel in the multimodality treatment for inflammatory breast carcinoma","volume":"92","author":"Cristofanilli","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3816\/CBC.2004.n.004","article-title":"Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: The M.D. Anderson Cancer Center experience","volume":"4","author":"Cristofanilli","year":"2004","journal-title":"Clin Breast Cancer"},{"issue":"Suppl.","key":"10.1016\/j.ijrobp.2009.06.042_bib14","first-page":"933s","volume":"24","author":"Ellis","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/02841860510029725","article-title":"Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: A\u00a0phase II study","volume":"44","author":"Kummel","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1503\/cmaj.1030944","article-title":"Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer","volume":"170","author":"Shenkier","year":"2004","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib17","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2005.06.233","article-title":"Evolving treatment strategies for inflammatory breast cancer: A population-based survival analysis","volume":"23","author":"Panades","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","article-title":"Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute","volume":"97","author":"Hance","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib19","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0360-3016(00)00561-7","article-title":"Locoregional irradiation for inflammatory breast cancer: Effectiveness of dose escalation in decreasing recurrence","volume":"47","author":"Liao","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0360-3016(02)04201-3","article-title":"Ten-year outcome after combined modality therapy for inflammatory breast cancer","volume":"55","author":"Harris","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/cncr.20083","article-title":"Inflammatory breast carcinoma: Outcomes with trimodality therapy for nonmetastatic disease","volume":"100","author":"Liauw","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","article-title":"Locoregional treatment outcomes after multimodality management of inflammatory breast cancer","volume":"72","author":"Bristol","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ijrobp.2004.04.044","article-title":"Postmastectomy CT-based electron beam radiotherapy: Dosimetry, efficacy, and toxicity in 118 patients","volume":"60","author":"Spierer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cncr.2820741337","article-title":"Postmastectomy radiotherapy in the management of operable breast cancer","volume":"74","author":"Pierce","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib25","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib26","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1200\/JCO.2004.10.147","article-title":"Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy","volume":"22","author":"Somlo","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000152938","article-title":"Clinicopathological features of inflammatory vs. noninflammatory locally advanced nonmetastatic breast cancer","volume":"29","author":"Brouwers","year":"2008","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0360-3016(83)90089-5","article-title":"Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day","volume":"9","author":"Thames","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0959-8049(05)80292-8","article-title":"Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysis","volume":"29A","author":"Attia-Sobol","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cncr.2820741336","article-title":"Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma","volume":"74","author":"Perez","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10549-005-9146-z","article-title":"No nodal cutoff in node-positive breast cancer women treated with mastectomy","volume":"98","author":"Vinh-Hung","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2009.06.042_bib32","article-title":"Clinical significance of axillary nodal ratio in stage II\/III breast cancer treated with neoadjuvant chemotherapy","author":"Keam","year":"2008","journal-title":"Breast Cancer Res Treat"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609009559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301609009559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T12:21:29Z","timestamp":1544876489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301609009559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0360301609009559"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.042","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}